Ullamari Pesonen

3.7k total citations
94 papers, 2.7k citations indexed

About

Ullamari Pesonen is a scholar working on Cellular and Molecular Neuroscience, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Ullamari Pesonen has authored 94 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cellular and Molecular Neuroscience, 37 papers in Physiology and 31 papers in Endocrine and Autonomic Systems. Recurrent topics in Ullamari Pesonen's work include Neuropeptides and Animal Physiology (31 papers), Regulation of Appetite and Obesity (30 papers) and Adipose Tissue and Metabolism (19 papers). Ullamari Pesonen is often cited by papers focused on Neuropeptides and Animal Physiology (31 papers), Regulation of Appetite and Obesity (30 papers) and Adipose Tissue and Metabolism (19 papers). Ullamari Pesonen collaborates with scholars based in Finland, United States and United Kingdom. Ullamari Pesonen's co-authors include Markku Koulu, Matti K. Karvonen, Risto Huupponen, Matti Uusitupa, Jaana Kallio, Raisa Valve, Juha Rouru, Markku Laakso, Aila Rissanen and Mika Scheinin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Ullamari Pesonen

92 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ullamari Pesonen Finland 29 948 795 717 711 420 94 2.7k
Pamela J. Hornby United States 33 698 0.7× 907 1.1× 736 1.0× 891 1.3× 585 1.4× 115 3.8k
Markku Koulu Finland 37 1.3k 1.4× 1.1k 1.3× 1.0k 1.4× 1.1k 1.5× 602 1.4× 123 4.3k
Annette L. Kirchgessner United States 38 1.1k 1.2× 903 1.1× 842 1.2× 1.2k 1.6× 708 1.7× 67 4.6k
Katsunori Nonogaki Japan 22 403 0.4× 848 1.1× 873 1.2× 693 1.0× 298 0.7× 71 2.7k
Giovanni Vacca Italy 34 1.4k 1.5× 302 0.4× 735 1.0× 741 1.0× 400 1.0× 160 4.2k
Paul Bertrand Australia 34 833 0.9× 504 0.6× 947 1.3× 1.1k 1.5× 524 1.2× 101 3.8k
Toku Takahashi United States 38 498 0.5× 755 0.9× 1.1k 1.5× 508 0.7× 975 2.3× 124 4.4k
Joseph S. Davison Canada 27 1.7k 1.8× 727 0.9× 937 1.3× 657 0.9× 684 1.6× 130 4.2k
David Engblom Sweden 32 1.2k 1.2× 393 0.5× 485 0.7× 1.1k 1.6× 140 0.3× 74 3.7k
Yoshikatsu Nakai Japan 35 685 0.7× 686 0.9× 790 1.1× 774 1.1× 445 1.1× 110 3.9k

Countries citing papers authored by Ullamari Pesonen

Since Specialization
Citations

This map shows the geographic impact of Ullamari Pesonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullamari Pesonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullamari Pesonen more than expected).

Fields of papers citing papers by Ullamari Pesonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ullamari Pesonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullamari Pesonen. The network helps show where Ullamari Pesonen may publish in the future.

Co-authorship network of co-authors of Ullamari Pesonen

This figure shows the co-authorship network connecting the top 25 collaborators of Ullamari Pesonen. A scholar is included among the top collaborators of Ullamari Pesonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ullamari Pesonen. Ullamari Pesonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prince, Stuart, et al.. (2024). Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis. Journal of Biological Chemistry. 300(8). 107507–107507.
2.
Gałȩzowski, Michał, Ullamari Pesonen, Harri M. Salo, et al.. (2023). 5-HT6 receptor antagonists. Design, synthesis, and structure–activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines. Bioorganic & Medicinal Chemistry Letters. 96. 129497–129497. 1 indexed citations
3.
Haapalinna, Antti, et al.. (2023). Development of an in vitro aggregation assay for long synthetic polypeptide, amyloidogenic gelsolin fragment AGelD187N 173–242. PLoS ONE. 18(8). e0290179–e0290179. 1 indexed citations
4.
Leino, Tiina, Timo Viitamaa, Jarmo S. Salonen, Ullamari Pesonen, & Antti Haapalinna. (2021). Effects of fadolmidine, an α2‐adrenoceptor agonist, as an adjuvant to spinal bupivacaine on antinociception and motor function in rats and dogs. Pharmacology Research & Perspectives. 9(4). e00830–e00830. 2 indexed citations
5.
Kovalainen, Miia, Juha Mönkäre, Joakim Riikonen, et al.. (2015). Novel Delivery Systems for Improving the Clinical Use of Peptides. Pharmacological Reviews. 67(3). 541–561. 59 indexed citations
6.
8.
Lehto, Soili M., Tommi Tolmunen, Pirjo Saarinen, et al.. (2010). Serotonin‐transporter‐linked promoter region polymorphism and serotonin transporter binding in drug‐naïve patients with major depression. Psychiatry and Clinical Neurosciences. 64(4). 387–393. 10 indexed citations
9.
Kuikka, Jyrki T., Eini Niskanen, Synnöve Carlson, et al.. (2008). Association of serotonin transporter promoter regulatory region polymorphism and cerebral activity to visual presentation of food. Clinical Physiology and Functional Imaging. 28(4). 270–276. 12 indexed citations
10.
Ruohonen, Suvi T., Ken Abe, Mia Kero, et al.. (2008). Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury. Peptides. 30(4). 715–720. 15 indexed citations
11.
Pesonen, Ullamari, et al.. (2006). The Leu7Pro Polymorphism of Neuropeptide Y is Associated with Younger Age of Onset of Type 2 Diabetes Mellitus and Increased Risk for Nephropathy in Subjects with Diabetic Retinopathy. Experimental and Clinical Endocrinology & Diabetes. 114(4). 147–152. 20 indexed citations
12.
Kallio, Jaana, et al.. (2003). Changes in Diurnal Sympathoadrenal Balance and Pituitary Hormone Secretion in Subjects with Leu7Pro Polymorphism in the Prepro-Neuropeptide Y. The Journal of Clinical Endocrinology & Metabolism. 88(7). 3278–3283. 27 indexed citations
13.
Pihlajamäki, Jussi, Pauli Karhapää, Ilkka Vauhkonen, et al.. (2003). The Leu7Pro polymorphism of the neuropeptide Y gene regulates free fatty acid metabolism. Metabolism. 52(5). 643–646. 14 indexed citations
14.
Kero, Jukka, Eriika Savontaus, Ullamari Pesonen, et al.. (2003). Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. American Journal of Physiology-Endocrinology and Metabolism. 285(4). E812–E818. 22 indexed citations
15.
Karvonen, Matti K., Veli-Pekka Valkonen, Timo A. Lakka, et al.. (2001). Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis. 159(1). 145–151. 80 indexed citations
16.
Niskanen, Leo, Markku Teräsvirta, Matti K. Karvonen, et al.. (2000). Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in Type 2 diabetes. Experimental and Clinical Endocrinology & Diabetes. 108(3). 235–236. 46 indexed citations
17.
Savontaus, Eriika, Juha Rouru, Kimmo Malminiemi, et al.. (2000). Effects of Chronic Celiprolol Treatment on Brown Fat, Feeding, and Drinking in fa/fa Zucker Rats. Pharmacology Biochemistry and Behavior. 65(4). 719–724.
18.
Savontaus, Eriika, Ullamari Pesonen, Juha Rouru, Risto Huupponen, & Markku Koulu. (1998). Effects of ZD7114, a selective β3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance. European Journal of Pharmacology. 347(2-3). 265–274. 9 indexed citations
19.
Rouru, Juha, Ullamari Pesonen, Markku Koulu, et al.. (1995). Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y. European Journal of Pharmacology. 273(1-2). 99–106. 32 indexed citations
20.
Rouru, Juha, et al.. (1995). Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats. British Journal of Pharmacology. 115(7). 1182–1187. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026